To validate the platform, we recapitulated findings from two previous studies examining WNT pathway alterations in high-risk CRC populations, including mutation prevalence in RNF43 and AXIN2 and survival outcomes associated with WNT pathway status across ethnic and age subgroups. Here, RNF43 is linked to colorectal carcinoma.